These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6085275)

  • 1. The chemistry of enalapril.
    Patchett AA
    Br J Clin Pharmacol; 1984; 18 Suppl 2(Suppl 2):201S-207S. PubMed ID: 6085275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The design and properties of N-carboxyalkyldipeptide inhibitors of angiotensin-converting enzyme.
    Patchett AA; Cordes EH
    Adv Enzymol Relat Areas Mol Biol; 1985; 57():1-84. PubMed ID: 2994404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue angiotensin converting enzyme inhibition as an index of the disposition of enalapril (MK-421) and metabolite MK-422.
    Cohen ML; Kurz KD; Schenck KW
    J Pharmacol Exp Ther; 1983 Jul; 226(1):192-6. PubMed ID: 6306224
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacological properties of the new non-sulfhydryl angiotensin converting enzyme inhibitor N-[8-amino-1(S)-carboxyoctyl]-L-alanyl-L-proline.
    Shirota M; Kajiwara Y; Iijima M; Kitabatake K
    Arzneimittelforschung; 1990 May; 40(5):515-9. PubMed ID: 2166521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of angiotensin converting enzyme (ACE) in the pharmacokinetics and pharmacodynamics of ACE inhibitors.
    Johnston CI; Jackson B; Cubela R; Larmour I; Arnolda L
    J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S9-14. PubMed ID: 2422495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enalapril, a nonsulfhydryl angiotensin-converting enzyme inhibitor.
    Vlasses PH; Larijani GE; Conner DP; Ferguson RK
    Clin Pharm; 1985; 4(1):27-40. PubMed ID: 2982541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-converting enzyme inhibitors: synthesis and biological activity of acyl tripeptide analogues of enalapril.
    Greenlee WJ; Allibone PL; Perlow DS; Patchett AA; Ulm EH; Vassil TC
    J Med Chem; 1985 Apr; 28(4):434-42. PubMed ID: 2984419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consequences of angiotensin-converting enzyme inhibitor overdose.
    Varughese A; Taylor AA; Nelson EB
    Am J Hypertens; 1989 May; 2(5 Pt 1):355-7. PubMed ID: 2541742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of enalapril, a new converting enzyme inhibitor, in hypertension.
    Ferguson RK; Vlasses PH; Swanson BN; Mojaverian P; Hichens M; Irvin JD; Huber PB
    Clin Pharmacol Ther; 1982 Jul; 32(1):48-53. PubMed ID: 6282527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age and the pharmacodynamics of angiotensin converting enzyme inhibitors enalapril and enalaprilat.
    Ajayi AA; Hockings N; Reid JL
    Br J Clin Pharmacol; 1986 Apr; 21(4):349-57. PubMed ID: 3011047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and angiotensin converting enzyme inhibitory activity of N-carboxymethyldipeptides with omega-(4-piperidyl)alkyl group.
    Waga T; Matsui S; Saito S; Watanabe M; Kajiwara Y; Shirota M; Iijima M; Kitabatake K
    Arzneimittelforschung; 1990 Apr; 40(4):407-13. PubMed ID: 2162675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enalapril maleate (MK-421), a potent, nonsulfhydryl angiotensin-converting enzyme inhibitor: absorption, disposition, and metabolism in man.
    Ulm EH
    Drug Metab Rev; 1983; 14(1):99-110. PubMed ID: 6301792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermodynamic determination of the binding constants of angiotensin-converting enzyme inhibitors by a displacement method.
    Andújar-Sánchez M; Jara-Pérez V; Cámara-Artigas A
    FEBS Lett; 2007 Jul; 581(18):3449-54. PubMed ID: 17618628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformationally restricted inhibitors of angiotensin converting enzyme: synthesis and computations.
    Thorsett ED; Harris EE; Aster SD; Peterson ER; Snyder JP; Springer JP; Hirshfield J; Tristram EW; Patchett AA; Ulm EH
    J Med Chem; 1986 Feb; 29(2):251-60. PubMed ID: 3005569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Angiotensin converting enzyme].
    Kokubu T; Takada Y
    Nihon Rinsho; 1982; 40(9):1956-63. PubMed ID: 6296486
    [No Abstract]   [Full Text] [Related]  

  • 16. Compared properties of trandolapril, enalapril, and their diacid metabolites.
    Chevillard C; Jouquey S; Bree F; Mathieu MN; Stepniewski JP; Tillement JP; Hamon G; Corvol P
    J Cardiovasc Pharmacol; 1994; 23 Suppl 4():S11-5. PubMed ID: 7527095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of enalapril on the in vitro and in vivo peptidyl cleavage of a potent VLA-4 antagonist.
    Karanam BV; Jayraj A; Rabe M; Wang Z; Keohane C; Strauss J; Vincent S
    Xenobiotica; 2007 May; 37(5):487-502. PubMed ID: 17523052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitor analysis of angiotensin I-converting and kinin-degrading activities of bovine lung and testicular angiotensin-converting enzyme.
    Grinshtein SV; Binevski PV; Gomazkov OA; Pozdnev VF; Nikolskaya II; Kost OA
    Biochemistry (Mosc); 1999 Aug; 64(8):938-44. PubMed ID: 10498812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of repeated single oral doses of enalapril maleate (MK-421) in normal volunteers.
    Till AE; Gomez HJ; Hichens M; Bolognese JA; McNabb WR; Brooks BA; Noormohamed F; Lant AF
    Biopharm Drug Dispos; 1984; 5(3):273-80. PubMed ID: 6091806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of specific inhibitors of angiotensin I converting enzyme (kininase II).
    Cushman DW; Cheung HS; Sabo EF; Rubin B; Ondetti MA
    Fed Proc; 1979 Dec; 38(13):2778-82. PubMed ID: 228989
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.